1. Magnitude of late effects of breast cancer treatments on shoulder function: a systematic review

   • Pamela K. Levangie
   • Jacqueline Drouin

   Review 25 November 2008 Pages: 1 - 15

2. Clinical proteomics in breast cancer: a review

   • Marie-Christine W. Gast
   • Jan H. M. Schellens
   • Jos H. Beijnen

   Review 11 December 2008 Pages: 17 - 29

   

3. Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways

   • Vivek Roy
   • Edith A. Perez

   Review 20 December 2008 Pages: 31 - 38

4. Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas

   • J. M. Del Casar
   • L. O. González
   • F. J. Vizoso

   Review 25 February 2009 Pages: 39 - 52

   

5. The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer

   • Robin L. Jones
   • Janine Salter
   • Mitchell Dowsett

   Preclinical Study 01 July 2008 Pages: 53 - 68

   

6. Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer

   • Alberto Calabrò
   • Tim Beissbarth
   • Holger Sültmann

   Preclinical Study 01 July 2008 Pages: 69 - 77

   

7. Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model

   • S. M. Eck
   • P. J. Hoopes
   • C. E. Brinckerhoff

   Preclinical Study 03 July 2008 Pages: 79 - 90

   

8. Expression of TNF-α leader sequence renders MCF-7 tumor cells resistant to the cytotoxicity of soluble TNF-α

   • Dan Yan
   • Nalin Qin
   • Zhuoya Li

   Preclinical Study 10 July 2008 Pages: 91 - 102

   

9. Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancer

   • Doris Auer
   • Daniel Reimer
   • Alain G. Zeimet

   Preclinical Study 10 July 2008 Pages: 103 - 111

   

10. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study

    • Catherine Quesnel
    • Josée Savard
    • Hans Ivers

    Clinical Trial 16 July 2008 Pages: 113 - 123

    

11. Neuropsychological studies in breast cancer: in search of chemobrain

    • Steven Castellon
    • Patricia A. Ganz

    Invited Commentary 16 October 2008 Pages: 125 - 127

12. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study

    • Catherine Quesnel
    • Josée Savard
    • Hans Ivers

    Erratum 08 October 2008 Pages: 129 - 130

13. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial

    • George Pentheroudakis
    • Konstantine T. Kalogeras
    • George Fountzilas

    Clinical Trial 31 July 2008 Pages: 131 - 143

    

14. Equivalency of RT-PCR and immunohistochemistry: fact or factoid

    • Sunil Badve

    Invited Commentary 12 September 2008 Pages: 145 - 147

15. Comparing two objective methods for the aesthetic evaluation of breast cancer conservative treatment

    • Maria João Cardoso
    • Jaime S. Cardoso
    • Florian Fitzal

    Clinical Trial 07 September 2008 Pages: 149 - 152

16. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy

    • Bhumsuk Keam
    • Seock-Ah Im
    • Yung-Jue Bang

    Clinical Trial 12 September 2008 Pages: 153 - 160

    

17. The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study

    • K. E. Pengel
    • C. E. Loo
    • K. G. A. Gilhuijs

    Clinical Trial 21 September 2008 Pages: 161 - 169

    

18. Factors predicting in-breast tumor recurrence after breast-conserving surgery

    • Robert Mechera
    • Carsten T. Viehl
    • Daniel Oertli

    Clinical Trial 25 September 2008 Pages: 171 - 177

    

19. Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias

    • Gill Lawrence
    • Matthew Wallis
    • Stephen W. Duffy

    Epidemiology 12 July 2008 Pages: 179 - 185

    

20. Pharmaceuticals that cause mammary gland tumors in animals: findings in women

    • Gary D. Friedman
    • Sheng-Fang Jiang
    • Laurel A. Habel

    Epidemiology 16 July 2008 Pages: 187 - 194

21. Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and P53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers

    • Tair Kontorovich
    • Yoram Cohen
    • Eitan Friedman

    Epidemiology 19 July 2008 Pages: 195 - 200

    

22. The economic burden of breast cancer in California

    • Wendy Max
    • Hai-Yen Sung
    • Brad Stark

    Epidemiology 06 August 2008 Pages: 201 - 207

23. Comments on: Yin W, Di G, Zhou L, Lu J, Liu G, Wu J, Shen K, Han Q, Shen Z, Shao Z. Time-varying pattern of recurrence risk for Chinese breast cancer patients

    • James J. Dignam
    • Vanja M. Dukic

    Letter to the Editor 21 June 2008 Pages: 209 - 210

24. No association of miscarriage and BRCA carrier status in Pakistani breast/ovarian cancer patients with a history of parental consanguinity

    • Muhammad U. Rashid
    • Diana Torres
    • Ute Hamann

    Letter to the Editor 24 June 2008 Pages: 211 - 213